Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Jounce Therapeutics Inc.
Goto 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-01-07
Sale
2022-01-11
8:57 pm
Jounce Therapeutics Inc. JNCE Trehu Elizabeth
Chief Medical Officer
8,383 $6.883 $57,700 85,202
(Direct)
View
2022-01-07
Sale
2022-01-11
8:57 pm
Jounce Therapeutics Inc. JNCE MURRAY RICHARD
CEO
37,294 $6.883 $256,696 185,577
(Direct)
View
2022-01-07
Sale
2022-01-11
8:56 pm
Jounce Therapeutics Inc. JNCE Drapkin Kimberlee C
CFO
12,817 $6.883 $88,220 52,614
(Direct)
View
2022-01-07
Sale
2022-01-11
8:55 pm
Jounce Therapeutics Inc. JNCE Cole Hugh M
Chief Business Officer
9,673 $6.883 $66,580 64,216
(Direct)
View
2021-11-12
Sale
2021-11-16
7:57 pm
Jounce Therapeutics Inc. JNCE Third Rock Ventures III L.P.
Third Rock Ventures GP III L.P.
TRV GP III LLC
STARR KEVIN P
TEPPER ROBERT I
LEVIN MARK J
10% Owner
1,900,000 $8.38 $15,922,000 4,698,661
(Indirect
Direct)
View
2021-05-25
Sale
2021-05-27
5:42 pm
Jounce Therapeutics Inc. JNCE Third Rock Ventures II L.P.
Third Rock Ventures GP II L.P.
TRV GP II LLC
STARR KEVIN P
TEPPER ROBERT I
LEVIN MARK J
10% Owner
552,520 $8 $4,420,160 9,387,176
(Indirect
Direct)
View
2021-04-15
Sale
2021-04-16
8:46 pm
Jounce Therapeutics Inc. JNCE Higgons John Duncan
Director
200 $10 $2,000 9,713
(Direct)
View
2021-03-29
Sale
2021-03-31
8:22 pm
Jounce Therapeutics Inc. JNCE Trehu Elizabeth
Chief Medical Officer
13,500 $10.09 $136,206 721,940
(Direct)
View
2021-03-15
Sale
2021-03-17
9:15 pm
Jounce Therapeutics Inc. JNCE Higgons John Duncan
Director
200 $12.8 $2,560 9,913
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-08-01
Option Award
2022-08-03
8:29 pm
N/A
2032-08-01
Jounce Therapeutics Inc. JNCE Cole Hugh M
Chief Operating Officer
60,000 $0 166,716
(Direct)
View
2022-06-24
Option Award
2022-06-28
9:08 pm
N/A
2032-06-24
Jounce Therapeutics Inc. JNCE Salter-Cid Luisa
Director
20,000 $0 20,000
(Direct)
View
2022-06-24
Option Award
2022-06-28
9:08 pm
N/A
2032-06-24
Jounce Therapeutics Inc. JNCE Raythatha Jigar
Director
20,000 $0 20,000
(Direct)
View
2022-06-24
Option Award
2022-06-28
9:07 pm
N/A
2032-06-24
Jounce Therapeutics Inc. JNCE KARSEN PERRY A
Director
20,000 $0 20,000
(Direct)
View
2022-06-24
Option Award
2022-06-28
9:06 pm
N/A
2032-06-24
Jounce Therapeutics Inc. JNCE Kamen Robert
Director
20,000 $0 20,000
(Direct)
View
2022-06-24
Option Award
2022-06-28
9:05 pm
N/A
2032-06-24
Jounce Therapeutics Inc. JNCE Iannone Robert
Director
20,000 $0 20,000
(Direct)
View
2022-06-24
Option Award
2022-06-28
9:03 pm
N/A
2032-06-24
Jounce Therapeutics Inc. JNCE Higgons John Duncan
Director
20,000 $0 20,000
(Direct)
View
2022-06-24
Option Award
2022-06-28
9:02 pm
N/A
2032-06-24
Jounce Therapeutics Inc. JNCE Duncan Barbara Gayle
Director
20,000 $0 20,000
(Direct)
View
2022-06-24
Option Award
2022-06-28
9:00 pm
N/A
2032-06-24
Jounce Therapeutics Inc. JNCE Diaz Luis
Director
20,000 $0 20,000
(Direct)
View
2022-02-01(A)
Option Award
2022-03-17
8:50 pm
N/A
2032-02-01
Jounce Therapeutics Inc. JNCE Cole Hugh M
Chief Business Officer
85,000 $0 85,000
(Direct)
View
2022-02-01
Option Award
2022-02-03
7:38 pm
N/A
2032-02-01
Jounce Therapeutics Inc. JNCE Cole Hugh M
Chief Business Officer
127,500 $0 191,716
(Direct)
View
2022-02-01
Option Award
2022-02-03
7:38 pm
N/A
2032-02-01
Jounce Therapeutics Inc. JNCE Drapkin Kimberlee C
CFO
82,500 $0 135,114
(Direct)
View
2022-02-01
Option Award
2022-02-03
7:37 pm
N/A
2032-02-01
Jounce Therapeutics Inc. JNCE MURRAY RICHARD
CEO
262,500 $0 448,077
(Direct)
View
2022-02-01
Option Award
2022-02-03
7:36 pm
N/A
2032-02-01
Jounce Therapeutics Inc. JNCE Trehu Elizabeth
Chief Medical Officer
82,500 $0 167,702
(Direct)
View
2021-09-15
Other
2021-09-17
4:15 pm
N/A
N/A
Jounce Therapeutics Inc. JNCE Third Rock Ventures II L.P.
Third Rock Ventures GP II L.P.
TRV GP II LLC
STARR KEVIN P
TEPPER ROBERT I
LEVIN MARK J
10% Owner
1,750,000 $0 8,348,661
(Direct)
View
2021-09-15
Other
2021-09-17
1:38 pm
N/A
N/A
Jounce Therapeutics Inc. JNCE Pfeffer Cary
Director
0 $0 50,468
(Indirect)
View
2021-09-13
Option Award
2021-09-15
08:16 am
N/A
2031-09-13
Jounce Therapeutics Inc. JNCE Raythatha Jigar
Director
31,400 $0 31,400
(Direct)
View
2021-06-18
Option Award
2021-06-22
4:50 pm
N/A
2031-06-18
Jounce Therapeutics Inc. JNCE Salter-Cid Luisa
Director
7,850 $0 7,850
(Direct)
View
2021-06-18
Option Award
2021-06-22
4:49 pm
N/A
2031-06-18
Jounce Therapeutics Inc. JNCE Pfeffer Cary
Director
15,700 $0 15,700
(Direct)
View
2021-06-18
Option Award
2021-06-22
4:49 pm
N/A
2031-06-18
Jounce Therapeutics Inc. JNCE Kamen Robert
Director
15,700 $0 15,700
(Direct)
View
2021-06-18
Option Award
2021-06-22
4:47 pm
N/A
2031-06-18
Jounce Therapeutics Inc. JNCE Iannone Robert
Director
15,700 $0 15,700
(Direct)
View
2021-06-18
Option Award
2021-06-22
4:46 pm
N/A
2031-06-18
Jounce Therapeutics Inc. JNCE Higgons John Duncan
Director
15,700 $0 15,700
(Direct)
View
2021-06-18
Option Award
2021-06-22
4:45 pm
N/A
2031-06-18
Jounce Therapeutics Inc. JNCE Duncan Barbara Gayle
Director
15,700 $0 15,700
(Direct)
View
2021-06-18
Option Award
2021-06-22
4:44 pm
N/A
2031-06-18
Jounce Therapeutics Inc. JNCE Diaz Luis
Director
15,700 $0 15,700
(Direct)
View
2021-06-18
Option Award
2021-06-22
4:34 pm
N/A
2031-06-18
Jounce Therapeutics Inc. JNCE KARSEN PERRY A
Director
15,700 $0 15,700
(Direct)
View
2021-06-10
Other
2021-06-14
4:23 pm
N/A
N/A
Jounce Therapeutics Inc. JNCE Pfeffer Cary
Director
0 $0 35,979
(Indirect)
View
2021-06-10
Other
2021-06-14
4:19 pm
N/A
N/A
Jounce Therapeutics Inc. JNCE Third Rock Ventures II L.P.
Third Rock Ventures GP II L.P.
TRV GP II LLC
STARR KEVIN P
TEPPER ROBERT I
LEVIN MARK J
10% Owner
1,500,000 $0 9,647,049
(Direct)
View
2021-03-29
Exercise
2021-03-31
8:22 pm
N/A
2025-11-12
Jounce Therapeutics Inc. JNCE Trehu Elizabeth
Chief Medical Officer
13,500 $0 721,940
(Direct)
View
2021-03-29
Exercise
2021-03-31
8:22 pm
N/A
N/A
Jounce Therapeutics Inc. JNCE Trehu Elizabeth
Chief Medical Officer
13,500 $4.02 721,940
(Direct)
View
2021-03-11
Other
2021-03-15
4:15 pm
N/A
N/A
Jounce Therapeutics Inc. JNCE Third Rock Ventures II L.P.
Third Rock Ventures GP II L.P.
TRV GP II LLC
STARR KEVIN P
TEPPER ROBERT I
LEVIN MARK J
10% Owner
1,250,000 $0 11,189,696
(Direct)
View
2021-03-11
Other
2021-03-15
4:15 pm
N/A
N/A
Jounce Therapeutics Inc. JNCE Pfeffer Cary
Director
0 $0 25,066
(Indirect)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, 3, Next